Moderna-Merck Vaccine Cuts Recurrence And Spread of Melanoma, Raises New Treatment Hope

Reuters reports "a major success in a new field of cancer treatment this week, as Moderna and Merck announced a personalized mRNA cancer vaccine "reduced the risk of recurrence and spread of melanoma in a late-stage trial". The vaccine was tested with Merck